diethylpropion hydrochloride

Key facts

INN

diethylpropion hydrochloride

Brand

TENUATE

Route

ORAL

Formulation

TABLET, EXTENDED RELEASE

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12409213

Live attenuated oral vaccine against shigellosis and typhoid fever

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12383566

Inhibition of SLC transporter activity or expression to attenuate anthracycline-

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12102671

Method of vaccination with an attenuated RSV vaccine formulation

Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12054519

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11813319

Development of a novel live attenuated African Swine Fever vaccine based in the

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11801296

Development of a novel live attenuated African swine fever vaccine based in the

Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11793870

Live attenuated strains of foot and mouth disease modified by deoptimization and

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11730801

Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use there

Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is diethylpropion hydrochloride?

diethylpropion hydrochloride (TENUATE), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for diethylpropion hydrochloride?

TENUATE is a marketed brand name for diethylpropion hydrochloride. Check FDA Drugs@FDA for the current US label holder.